PerpEquities

Microchip Technology Incorporated (MCHP) financials

NASDAQ · Technology · Semiconductors · 17,900 employees · CEO Steve Sanghi

Price
$77.34 -4.66%
Market cap
$42B
Enterprise value
$47.1B
Last report
Q1 '27 filed 2026-08-06
Next report
2026-11-05 EPS est. $0.94
Revenue (TTM)$5.12B+20.9% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)15.5%+12.9 pp vs a year agoOperating income $795M
Net income (TTM)$451M+403.6% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$1.11B+53.1% vs a year agoCapex $87.1M
Diluted EPS (TTM)$0.72+314.7% vs a year agoSum of the last 4 quarters
Net cash-$5.13B-4.0% vs a year agoCash + short-term investments - debt

Valuation & key figures

Market cap
$42B
EV $47.1B
Revenue
$5.12B
Trailing 12 months
Revenue growth
+36%
FY2027 consensus
Profit margin
8.8%
Net income / revenue, TTM
P/E
107.2×
Forward 21.2× (FY2027)
P/S
8.2×
Price / sales, TTM
EV / EBITDA
28.0×
TTM
Free cash flow
$1.11B
Trailing 12 months
Net income
$451M
Trailing 12 months
Revenue estimate
$6.41B
FY2027 consensus
Earnings
2026-11-05
Revenue est. $1.61B
Dividend
$1.82
Per share, last 12 months

Key takeaways

Computed from the reported numbers - every statement carries the figure it rests on.

  • Last report (2026-08-06): revenue beat by 1.8%, EPS beat by 8.6%Revenue $1.48B vs $1.46B expected (+1.8%); EPS $0.76 vs $0.70 (+8.6%).
  • Revenue growth accelerating: 38.0% year on yearQ1 '27 revenue $1.48B, against an average of 8.8% over the four quarters before.
  • Operating margin 15.5% (TTM), +12.9 pp on a year agoOperating income grew 627.2% while revenue grew 20.9%.
  • 37.2% of pre-tax profit is eaten by non-operating lossesPre-tax income $579M vs operating income $795M (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.
  • Capex 1.7% of revenue (a year ago 1.7%)$87.1M invested in the last 4 quarters (+22.7% on a year earlier). Free cash flow $1.11B = 246.5% of net income.
  • Returned $985M to shareholders = 88.7% of free cash flowBuybacks $0 (a year earlier $23.8M), dividends $985M, stock-based pay $278M (TTM).
  • Diluted share count up 2.1% in a year551M diluted shares in Q1 '27, 539M a year earlier.
  • Net debt $5.13BCash + short-term investments $272M, debt incl. leases $5.4B; a year ago net debt $4.93B.

Last quarter: Q1 '27

Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.

Quarter vs a year ago

Q1 '27Year agoChange
Revenue$1.48B$1.08B+38.0%
Gross margin63.2%53.6%+9.6 pp
Operating income$337M$32.1M+949.2%
Operating margin22.7%3.0%+19.7 pp
Net income$230M-$18.6M+1,335.5%
Diluted EPS$0.37-$0.09+529.7%
Operating cash flow$512M$276M+85.6%
Capex$13.9M$17.9M-22.3%
Free cash flow$498M$258M+93.1%
R&D$309M$256M+20.9%
Stock-based compensation$75M$52.9M+41.8%

Reported vs consensus

2026-08-06
ActualConsensusvs consensus
Revenue$1.48B$1.46B+1.8%
EPS (as estimated)$0.76$0.70+8.6%

From the report of 2026-08-06 for Q1 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.

EPS vs consensus

last 8 reports

Revenue

Where the money comes from - by business line and by region, quarter by quarter.

Revenue, operating income and growth

quarterly

Revenue by business line

stacked, quarterly
SegmentQ1 '27y/yShareTTMTTM y/y12 quarters
Semiconductor Products Member$1.44B+38.3%97.1%$4.95B+20.9%
Technology Licensing Member$42.6M+29.1%2.9%$173M+22.2%

Margins & cost structure

How much of each unit of revenue is left at each level - and where the costs go.

Margins

quarterly

Costs as % of revenue

quarterly

Cash flow & capital allocation

Cash generated, what it is spent on, and what reaches shareholders.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Last 4 quarters

cash flow statement
Operating cash flow
$1.2B
Capex
-$87.1M
Buybacks
$0
Dividends
-$985M
Acquisitions
$0
Net debt issued
-$91M
Stock-based compensation
$278M
Free cash flow
$1.11B
Returned to shareholders / FCF
88.7%

Share count and EPS

quarterly, diluted

Balance sheet

Liquidity, investments and debt at each quarter end.

Cash, investments and debt

quarter ends

Valuation & returns

Today's multiples against the company's own last five fiscal years; analyst targets and ratings.

Multiples and returns

TTM vs 5 fiscal years
Now5y averageWhere today sits in the 5-year range
P/E (TTM)107.2×79.4× 4 of 5 years20.6× – 239.3×
EV / EBITDA28.0×20.8×12.8× – 29.7×
EV / Sales9.2×7.2×6.2× – 8.5×
Price / FCF37.8×24.8×14.7× – 40.2×
Price / Book6.5×6.1×3.7× – 7.3×
FCF yield2.6%4.7%2.5% – 6.8%
Return on invested capital5.0%8.9%-0.0% – 16.3%
Return on equity6.9%17.6%-0.0% – 34.4%

Analysts

Consensus target $110.50 (+42.9%)
range $88.00 – $135.00 · rating Buy

Strong buy2
Buy30
Hold14
Sell0
Strong sell0

Outlook

Analyst consensus for the coming fiscal years and what it implies at today's price.

Consensus estimates

Fiscal yearRevenueGrowthEPSGrowthP/E at today's priceAnalysts (EPS)
FY2027$6.41B+35.9%$3.65+1,304.5%21.2×17
FY2028$7.47B+16.6%$4.59+25.7%16.8×17
FY2029$8.24B+10.3%$5.23+13.9%14.8×5

Financial statements

Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.

Every reported line

All 272 figures Microchip Technology Incorporated tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).

Line (SEC label)Latest quarterYear agoy/yLatest FYPrior FYy/y
–––-$2.6M––
–––-0.9%––
–––$43M––
–––15.7%––
–––$166M––
–––$3.4M––
Accounts Payable, Current$229M$162M+41.4%$206M$161M+28.0%
Accounts Receivable, after Allowance for Credit Loss, Current$968M$766M+26.4%$895M$690M+29.7%
Accounts Receivable, Allowance for Credit Loss, Current$5.3M$5.7M-7.0%$5.3M$5.9M-10.2%
Accounts Receivable, before Allowance for Credit Loss, Current$973M$771M+26.2%$900M$696M+29.4%
Accrued Income Taxes, Current$43.1M$86.2M-50.0%$24.3M$99.1M-75.5%
Accrued Income Taxes, Noncurrent$580M$640M-9.4%$571M$633M-9.9%
Accrued Liabilities and Other Liabilities$270M$251M+7.3%$218M$209M+4.5%
Accrued Liabilities, Current$1.07B$1.03B+3.6%$931M$995M-6.4%
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment$2.64B$2.37B+11.1%$2.6B$2.34B+11.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax-$3.7M-$6.4M+42.2%-$4.2M-$1.7M-147.1%
Additional Paid in Capital, Common Stock$4.12B$3.97B+3.6%$4.07B$3.91B+4.1%
Amortization of Debt Discount (Premium)$3.9M$1.4M+178.6%$27.2M$64.8M-58.0%
Amortization of Debt Issuance Costs$2.3M$1.4M+64.3%$5.9M$7.8M-24.4%
Amortization of Intangible Assets$119M$132M-9.7%$534M$584M-8.6%
APIC, Share-based Payment Arrangement, Increase for Cost Recognition$77.7M$52.3M+48.6%$260M$190M+37.4%
Asset Impairment Charges–––$400K$0–
Assets$14.4B$15B-3.8%$14.4B$15.4B-6.5%
Assets, Current$2.49B$2.75B-9.7%$2.38B$2.99B-20.5%
Business Exit Costs–––$14.5M$45.7M-68.3%
Cash and Cash Equivalents, at Carrying Value$272M$567M-51.9%$240M$772M-68.9%
Cash and Cash Equivalents, Fair Value Disclosure$02026-03-31$491M-100.0%$0$491M-100.0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$272M$567M-51.9%$240M$772M-68.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect$32M-$205M+115.6%-$531M$452M-217.6%
Common Stock, Dividends, Per Share, Cash Paid–––$1.82$1.82+0.2%
Common Stock, Dividends, Per Share, Declared$0.46$0.460.0%$1.82$1.82+0.2%
Common Stock, Par or Stated Value Per Share$0.00$0.000.0%$0.00$0.000.0%
Common Stock, Shares Authorized900M900M0.0%900M900M0.0%
Common Stock, Shares, Issued578M578M0.0%578M578M+0.1%
Common Stock, Shares, Outstanding543M540M+0.6%542M539M+0.6%
Common Stock, Value, Issued$600K$600K0.0%$600K$600K0.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent$230M-$23.3M+1,088.4%$228M$1.3M+17,400.0%
Cost of Revenue$546M$499M+9.4%$1.99B$1.93B+3.0%
Current Federal Tax Expense (Benefit)–––$51.7M$128M-59.5%
Current Foreign Tax Expense (Benefit)–––$52.9M$55.2M-4.2%
Current Income Tax Expense (Benefit)–––$108M$183M-40.8%
Current State and Local Tax Expense (Benefit)–––$3.5M$0–
Debt Instrument, Face Amount$1K$1K0.0%$1K$1K0.0%
Debt Instrument, Unamortized Discount$8.4M$11.4M-26.3%$9.3M$13.1M-29.0%
Debt Issuance Costs, Net$29.2M$18.5M+57.8%$31.2M$19.5M+60.0%
Deferred Federal Income Tax Expense (Benefit)–––-$21.6M-$101M+78.6%
Deferred Foreign Income Tax Expense (Benefit)–––-$40.8M-$36.8M-10.9%
Deferred Income Tax Assets, Net$1.78B$1.73B+2.7%$1.79B$1.73B+3.7%
Deferred Income Tax Expense (Benefit)$11.4M-$3M+480.0%-$64.6M-$143M+54.9%
Deferred Income Tax Liabilities, Net$25.4M$36.3M-30.0%$25.1M$33.8M-25.7%
Deferred Revenue, Current$174M$160M+8.8%$179M$213M-16.0%
Deferred State and Local Income Tax Expense (Benefit)–––-$2.2M-$5.5M+60.0%
Deferred Tax Assets, Capital Loss Carryforwards$10.1M2026-03-31$9.8M+3.1%$10.1M$9.8M+3.1%
Deferred Tax Assets, Goodwill and Intangible Assets$1.08B2026-03-31$1.19B-9.3%$1.08B$1.19B-9.3%
Deferred Tax Assets, Gross$2.12B2026-03-31$2.07B+2.9%$2.12B$2.07B+2.9%
Deferred Tax Assets, Inventory$145M2026-03-31$130M+10.8%$145M$130M+10.8%
Deferred Tax Assets, Net$1.77B2026-03-31$1.69B+4.3%$1.77B$1.69B+4.3%
Deferred Tax Assets, Net of Valuation Allowance$1.83B2026-03-31$1.78B+3.1%$1.83B$1.78B+3.1%
Deferred Tax Assets, Operating Loss Carryforwards$62.4M2026-03-31$59.3M+5.2%$62.4M$59.3M+5.2%
Deferred Tax Assets, Property, Plant and Equipment$15.4M2026-03-31$0–$15.4M$0–

Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-K 2026-03-31, 10-Q 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-K 2025-03-31, 10-Q 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-02